YALE UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1701-10-09
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.yale.edu
A Trial of a Multi-component Individualized Telephone-based Support Intervention for Adult-child Caregivers Caring for Parents With Dementia
Not Applicable
Withdrawn
- Conditions
- Dementia
- Interventions
- Other: Usual CareBehavioral: HEART
- First Posted Date
- 2017-12-19
- Last Posted Date
- 2021-04-20
- Lead Sponsor
- Yale University
- Registration Number
- NCT03378050
Global Response Assessment by Advanced Imaging and Myeloma Lesion Biopsies During Induction Therapy of Multiple Myeloma With Carfilzomib Lenalidomide Dexamethasone
Not Applicable
Completed
- Conditions
- Multiple Myeloma
- Interventions
- Procedure: Guided Lesion BiopsiesProcedure: Standard Lesion Biopsies
- First Posted Date
- 2017-12-18
- Last Posted Date
- 2022-02-24
- Lead Sponsor
- Yale University
- Target Recruit Count
- 28
- Registration Number
- NCT03375567
- Locations
- 🇺🇸
Yale Cancer Center, New Haven, Connecticut, United States
Targeting Self-regulatory Deficits Through Cognitive Remediation Intervention
Not Applicable
Completed
- Conditions
- Drug Use Disorders
- Interventions
- Behavioral: TAU plus Control TasksBehavioral: TAU plus Cognitive Remediation Program
- First Posted Date
- 2017-12-14
- Last Posted Date
- 2021-01-08
- Lead Sponsor
- Yale University
- Target Recruit Count
- 46
- Registration Number
- NCT03373240
- Locations
- 🇺🇸
Substance Abuse Treatment Center (SATU), New Haven, Connecticut, United States
Home vs. Office Foley Catheter Removal in Women With Voiding Difficulty Following Pelvic Reconstructive Surgery
Not Applicable
Completed
- Conditions
- Voiding Disorders
- Interventions
- Procedure: Foley catheter removal
- First Posted Date
- 2017-12-14
- Last Posted Date
- 2022-08-29
- Lead Sponsor
- Yale University
- Target Recruit Count
- 78
- Registration Number
- NCT03373773
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
The PrISICE Clinical Trial (Pre-Implantation Screening and Investigation on the Cryopreservation of Embryos)
Not Applicable
Terminated
- Conditions
- Infertility
- Interventions
- Procedure: Trophectoderm biopsyProcedure: CryopreservationProcedure: Embryo Transfer
- First Posted Date
- 2017-12-13
- Last Posted Date
- 2022-10-03
- Lead Sponsor
- Yale University
- Target Recruit Count
- 32
- Registration Number
- NCT03371745
- Locations
- 🇺🇸
University of California San Francisco, San Francisco, California, United States
🇺🇸University of Oklahoma, Oklahoma City, Oklahoma, United States
🇺🇸University of Pennsylvania, Philadelphia, Pennsylvania, United States
Translating Neuroprediction Into Precision Medicine Via Brain Priming
Phase 2
Terminated
- Conditions
- Autism Spectrum Disorder
- Interventions
- First Posted Date
- 2017-12-12
- Last Posted Date
- 2022-08-09
- Lead Sponsor
- Yale University
- Target Recruit Count
- 5
- Registration Number
- NCT03370510
- Locations
- 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response, Pilot Trial
Phase 1
Completed
- Conditions
- Depressive Disorder, MajorPost Traumatic Stress DisorderBipolar Disorder
- Interventions
- First Posted Date
- 2017-12-08
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Yale University
- Target Recruit Count
- 13
- Registration Number
- NCT03367533
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
An Efficacy Trial of Low Dose All-trans Retinoic Acid in Patients With Primary Sclerosing Cholangitis
- First Posted Date
- 2017-12-02
- Last Posted Date
- 2021-08-09
- Lead Sponsor
- Yale University
- Target Recruit Count
- 2
- Registration Number
- NCT03359174
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.
Phase 1
Completed
- Conditions
- Obsessive-Compulsive Disorder
- Interventions
- First Posted Date
- 2017-11-29
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Yale University
- Target Recruit Count
- 31
- Registration Number
- NCT03356483
- Locations
- 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States
Development of Agents to Diminish the Risk of Hypoglycemia-induced Brain Injury in Type 1 Diabetes
Early Phase 1
Completed
- Conditions
- Hyperglycaemia (Diabetic)
- Interventions
- Drug: Placebo oral capsule
- First Posted Date
- 2017-11-29
- Last Posted Date
- 2021-01-22
- Lead Sponsor
- Yale University
- Target Recruit Count
- 21
- Registration Number
- NCT03356457
- Locations
- 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States
© Copyright 2025. All Rights Reserved by MedPath